# Towards the Development of Effective Antioxidants—The Molecular Structure and Properties—Part 2

**Authors:** Hanna Lewandowska, Renata Świsłocka, Waldemar Priebe, Włodzimierz Lewandowski, Sylwia Orzechowska

PMC · DOI: 10.3390/molecules31040720 · Molecules · 2026-02-19

## TL;DR

This paper reviews recent advances in understanding how antioxidant molecular structures affect their function, combining computational and experimental methods to guide better antioxidant design.

## Contribution

The paper integrates computational models with advanced synchrotron techniques to explain antioxidant mechanisms and guide formulation engineering.

## Key findings

- Polyphenolic architecture and electronic descriptors influence antioxidant activity through HAT, SET, and SPLET pathways.
- Metal coordination can stabilize antioxidants or trigger pro-oxidant effects via ligand-to-metal charge transfer.
- Computational and synchrotron methods validate antioxidant behavior and inform nanocarrier design for drug delivery.

## Abstract

The development of effective antioxidants has evolved from descriptive analysis toward a precise, mechanism-driven discipline targeting the molecular “redox switch”. This review synthesizes the critical advances reported since 2021, focusing on how the interplay between polyphenolic architecture and electronic descriptors, such as bond dissociation enthalpy and ionization potential, governs radical scavenging through the HAT, SET, and SPLET pathways. We evaluate the dual influence of metal coordination, where interactions can either enhance antioxidant stability through σ bond polarization or trigger pro-oxidant transitions via ligand-to-metal charge transfer. Central to this progress is the integration of computational models (DFT, QSAR) with advanced synchrotron methodologies (XAS, STXM, SR-FTIR, and SAXS), which provide element-specific validation of antioxidant behavior and subcellular oxidative mapping within complex matrices. Furthermore, we highlight how these molecular insights inform formulation engineering, specifically the development of organic nanocarriers and hybrid delivery systems, such as metal–phenolic networks, that shield therapeutic cargo from degradation and govern release in challenging physiological environments. These fundamental studies provide an essential physicochemical basis for medicine by enabling a better understanding and the rational design of antioxidant drugs, dietary supplements, and antioxidant strategies.

## Full-text entities

- **Genes:** TMPRSS11D (transmembrane serine protease 11D) [NCBI Gene 9407] {aka ASP, HAT}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}
- **Diseases:** hemolysis (MESH:D006461), cancer (MESH:D009369), SPLET (MESH:D054069), injury to (MESH:D014947), inflammation (MESH:D007249), XAS (MESH:C562790), cytotoxic (MESH:D064420)
- **Chemicals:** Copper (MESH:D003300), Ascorbic acid (MESH:D001205), RH (MESH:D012238), isoprene (MESH:C005059), hydroxybenzoic acids (MESH:D062385), thymol (MESH:D013943), Ag+ (MESH:D012834), resveratrol (MESH:D000077185), 1,10-phenanthroline (MESH:C025205), hydroxyl (MESH:D017665), hydroxytyrosol (MESH:C005975), quinic acid (MESH:D011801), ethanol (MESH:D000431), para-aminophenol (MESH:C026729), Carotenoids (MESH:D002338), free radical (MESH:D005609), fluorine (MESH:D005461), kaempferol (MESH:C006552), Water (MESH:D014867), Phenol (MESH:D019800), ellagitannins (MESH:D047348), +)-catechin (MESH:D002392), essential oil (MESH:D009822), cinnamic acids (MESH:C029010), coumarin (MESH:C030123), BHT (MESH:D002084), Catechol (MESH:C034221), Fe (MESH:D007501), Phenolic acids (MESH:C017616), myricetin (MESH:C040015), prostaglandin (MESH:D011453), Quercetin (MESH:D011794), Vitamin E (MESH:D014810), N (MESH:D009584), TA (MESH:D013635), NO2 (MESH:D009585), polysaccharide (MESH:D011134), oxalate (MESH:D010070), bacillibactin (MESH:C430721), ethylene (MESH:C036216), hydroxycinnamic acids (MESH:D003373), C (MESH:D002244), flavonols (MESH:D044948), ascorbyl radical (MESH:C000820), SnO2 (MESH:C045358), rutin (MESH:D012431), polymer (MESH:D011108), ester (MESH:D004952), DPPH (MESH:C004931), Stilbenes (MESH:D013267), singlet oxygen (MESH:D026082), 2,6-di-tert-butylphenol (MESH:C035407), Metal (MESH:D008670), flavan-3-ols (MESH:C404987), platinum (MESH:D010984), quinones (MESH:D011809), azotochelin (MESH:C041892), azetidinone (MESH:C116379), Zn (MESH:D015032), O (MESH:D010100)
- **Species:** Azotobacter vinelandii (species) [taxon 354], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), HepG-2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942762/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12942762/full.md

## References

127 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942762/full.md

---
Source: https://tomesphere.com/paper/PMC12942762